Biologica Technologies announced the launch of its Allofill device during the American Society of Plastic Surgeons conference in Los Angeles.

Allofill is a ready-to-use, adipose-derived injectable filler that works with the body to provide an all-natural tissue scaffold with native growth factors.  Allofill retains the native extracellular matrix (ECM) components of allograft-derived adipose tissue and over time will be remodeled into a patient's own soft tissue.

This allograft product provides higher growth factors than a standard autologous fat transfer and is more natural than an HA, or similar, dermal filler, Biologica said. — Cynthia Jessup